Observation on the effect of repaglinide combined with metformin in treatment of patient with type 2 diabetes
10.3760/cma.j.issn.1008-6706.2011.21.011
- VernacularTitle:瑞格列奈联合二甲双胍治疗2型糖尿病的疗效观察
- Author:
Hu QU
- Publication Type:Journal Article
- Keywords:
Diabetes mellitus,type 2;
Repaglinide;
Metformin
- From:
Chinese Journal of Primary Medicine and Pharmacy
2011;18(21):2901-2902
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo explore the application value of repaglinide combined with metformin in type 2 diabetes therapy.Methóds92 patients with type 2 diabetes were randomly divided into study group and control group.Two groups of patients were given repaglinide treatment,patients in study group given metformin treatment.The blood lipid,glucose metabolism,body weight change and clinical outcomes were compared belween the groups.ResultsCompared with the control group,study group the cure rate and total effective rate was significantly increased,as high as 58.7％ and 97.8％,the ineffective rate was significantly decreased,only 2.2％,there were significant differences ( x2 =2.64,3.59,3.59,P ＜ 0.05 ).The fasting and 2h postprandial blood glucose and glycated hemoglobin and other indicators of glucose metabolism in the study group were significantly decreased,there were also significant differences(P ＜ 0.05 ).The triglycerides and cholesterol and other lipid levels and body mass index in the study group were significantly decreased,there were significant differences ( P ＜ 0.05 ).ConclusionRepaglinide combined with metformin in type 2 diabetes treatment was remarkable for type 2 diabetes to further improve the clinical efficacy.
